Abstract

BackgroundThe aim of this study is to investigate the reliability, validity, and responsiveness of JOACMEQ for CSM patients in mainland China.MethodsA retrospective review was performed on 91 patients with CSM in our hospital from March 2015 to June 2015. Patients completed the JOACMEQ, the mJOA and the SF-36 questionnaires during the process. Cronbach's α was used to evaluate the internal consistency reliability, and test–retest reliability was checked. An exploratory factor analysis was used to determine the correlations among the JOACMEQ questions and the construct validity. The concurrent validity was assessed by Spearman correlation coefficient. The internal responsiveness was determined by effect sizes and standardized response means. External responsiveness was determined by the area under the receiver operating characteristic curve on the basis of the Youden Index.ResultsThe mean age of patients was 57.61 years old. The mean follow-up was 24 months. JOACMEQ showed a good internal consistency (Cronbach's α, 0.897). Test–retest reliability showing good result (Pearson's correlation, 0.695–0.905). Our data were amenable to factor analysis (KMO = 0.816, Bartlett's test, χ2(45) = 1199.99, p < 0.001), and five factors above 1 were strongly loaded and clustered for each of the five factors. Comparing the scales preoperative to those 2 years postoperative, the average scores of the subscales all increased, and both the ES and SRM showing satisfied responsiveness. In external responsiveness analysis, the recovery rate a appeared to be most responsive to post-operative improvement.ConclusionsThe Simplified Chinese version of JOACMEQ was well-developed with great reliability and sensitive responsiveness. Our study demonstrated that JOACMEQ has content psychometric properties to identify postoperative improvements in CSM patients.

Highlights

  • The aim of this study is to investigate the reliability, validity, and responsiveness of Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) for Cervical spondylotic myelopathy (CSM) patients in mainland China

  • Full list of author information is available at the end of the article

  • All CSM patients were assessed by the Chinese modified Japanese Orthopaedic Association (mJOA), the Chinese social function (SF)-36 and final Chinese version of JOACMEQ about one week before surgery, a subgroup of 30 patients were each evaluated two times one week apart and all CSM patients were assessed again at around 2 years after surgery

Read more

Summary

Introduction

The aim of this study is to investigate the reliability, validity, and responsiveness of JOACMEQ for CSM patients in mainland China. Many researchers have established neurological function rating scales to define the severity of neurological disorders and to evaluate the efficacy of surgical intervention. These scales are called disease-specific outcome measurements. Evaluations based on the subjective feelings of patients have gradually attracted more attention. These generic outcome measurements have been widely used with the goal of evaluating patients’ quality of life and have been applied to all types of diseases. There is currently no evaluation scale that accounts for both disease-specific evaluation and general health evaluation to assess Chinese CSM patients

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call